Therapeutic Climbing for Children With DCD (Climbing TDC)
27 maggio 2026 aggiornato da: Université de Sherbrooke
Therapeutic Group Climbing for Children With Developmental Coordination Disorder: Randomized Crossover Trial
This study looks at whether therapeutic climbing - indoor climbing activities guided by therapists - can help children with Developmental Coordination Disorder (DCD).
DCD is a condition where children have difficulty with motor skills and participation in everyday activities, and sometimes confidence in physical activities.
The climbing program is based on a problem-solving approach called CO-OP (Cognitive Orientation to daily Occupational Performance), in which children learn strategies to achieve goals.
Panoramica dello studio
Stato
Non ancora reclutamento
Intervento / Trattamento
Descrizione dettagliata
Background: Therapeutic climbing, based on the Cognitive Orientation to daily Occupational Performance (CO-OP) approach, may improve goal performance and satisfaction in children with Developmental Coordination Disorder (DCD), as well as their motivation and self-efficacy toward physical activity.
Objective: This study aims to examine the effectiveness of a CO-OP-based group therapeutic climbing intervention for children with DCD.
Methods: A randomized crossover trial will be conducted with children with DCD. The intervention will consist of a 10-week group-based therapeutic climbing program delivered in an indoor climbing setting. Primary outcomes will include performance and satisfaction related to individualized goals. Secondary outcomes will assess motor skills, self-efficacy, executive functions, motivation toward physical activity, and transfer of learning. Effects of the intervention will be assessed using linear mixed effects models.
Results: It is hypothesized that participants will demonstrate improvements in both primary and secondary outcomes following the intervention.
Conclusions: This study will contribute to the evidence base regarding therapeutic climbing and CO-OP-based interventions for children with DCD, informing future rehabilitation practices.
Tipo di studio
Interventistico
Iscrizione (Stimato)
16
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
- Nome: Emmanuelle Jasmin, Ph.D.
- Numero di telefono: 1-819-342-0305
- Email: emmanuelle.jasmin@usherbrooke.ca
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Bambino
Accetta volontari sani
No
Descrizione
Inclusion Criteria:
- Diagnosis of DCD by a physician*.
- Ability to follow instructions, communicate verbally, interact with adults and peers, and use cognitive strategies.
- Ability to attend all assessment and intervention sessions in Sherbrooke.
- Ability to understand and speak French.
- Provision of child assent and parental consent. * If the target sample size (n = 16) is not reached, children with suspected DCD based on the Developmental Coordination Disorder Questionnaire (DCDQ) (25,26) will also be considered. Eligibility will then require: (1) a score below the 15th percentile on the total motor composite or below the 5th percentile in a domain of the Bruininks-Oseretsky Test of Motor Proficiency (BOT) (27,28), and (2) the identification of occupational challenges using the Canadian Occupational Performance Measure (COPM) (29,30) during the initial assessment.
Exclusion Criteria:
- Diagnosis of severe behavioral disorders, autism spectrum disorder, intellectual disability, cerebral palsy, muscular dystrophy, and/or severe functional limitations.
- Prior proficiency in climbing or absence of climbing-related goals.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Group 1 - Fall 2026
First group intervention
|
The intervention will consist of a 10-week group-based therapeutic climbing program delivered once weekly on Saturday afternoons at an indoor climbing center.
Sessions will be delivered by an occupational therapist (OT), two occupational therapy interns, and a certified climbing monitor (hereafter referred to as "intervention providers").
Each 90-minute session will follow the same global structure.
The intervention is grounded in the CO-OP approach.
|
|
Sperimentale: Group 2 - Winter 2027
Second group intervention
|
The intervention will consist of a 10-week group-based therapeutic climbing program delivered once weekly on Saturday afternoons at an indoor climbing center.
Sessions will be delivered by an occupational therapist (OT), two occupational therapy interns, and a certified climbing monitor (hereafter referred to as "intervention providers").
Each 90-minute session will follow the same global structure.
The intervention is grounded in the CO-OP approach.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Performance related to individualized goals
Lasso di tempo: Baseline (2-3 months before the intevention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Canadian Occupational Performance Measure (COPM) (visual analog scale of 1-10)
|
Baseline (2-3 months before the intevention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Satisfaction related to individualized goals
Lasso di tempo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Canadian Occupational Performance Measure (COPM) (visual analog scale of 1-10)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Performance related to climbing-specific goals
Lasso di tempo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Performance Quality Rating Scale (PQRS) (visual analog scale of 1-10)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Motor skills
Lasso di tempo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Bruininks-Oseretsky Test of Motor Proficiency, Third Edition (BOT-3) (standard scores (mean = 50, SD = 10) or scale scores for subtests (mean = 10, SD = 3))
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Self-efficacy
Lasso di tempo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the French adaptation of the General Self-Efficacy Scale (GSES) (5-point Likert scale)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Executive functioning
Lasso di tempo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) T-scores (mean = 50, SD = 10)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
|
Motivation for physical activity
Lasso di tempo: Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Assess with the Pictorial Motivation Scale (PMS) for physical activity (3-point scale)
|
Baseline (2-3 months before the intervention, pre-intervention (immediatly before the intervention), post-intervention (immediatly after the intervention), follow-up 2-3 months post-intervention
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Emmanuelle Jasmin, Ph.D., Université de Sherbrooke
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
15 maggio 2026
Completamento primario (Stimato)
6 giugno 2026
Completamento dello studio (Stimato)
6 giugno 2026
Date di iscrizione allo studio
Primo inviato
12 maggio 2026
Primo inviato che soddisfa i criteri di controllo qualità
19 maggio 2026
Primo Inserito (Effettivo)
27 maggio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
1 giugno 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
27 maggio 2026
Ultimo verificato
1 maggio 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 2026-6195
- Mental health 2025-2026 (Altro identificatore: Pediatric Research Foundation)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .